Decline in FEV1 related to smoking status in individuals with severe α1-antitrypsin deficiency (PiZZ)

被引:95
作者
Piitulainen, E [1 ]
Eriksson, S
机构
[1] Lund Univ, Malmo Hosp, Dept Lung Med, S-20502 Malmo, Sweden
[2] Lund Univ, Malmo Hosp, Dept Med, S-20502 Malmo, Sweden
关键词
alpha(1)-antitrypsin deficiency; lung function decline; smoking; smoking cessation;
D O I
10.1183/09031936.99.13224799
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Severe alpha(1)-antitrypsin (AAT) deficiency predisposes to emphysema development. Highly variable rates of decline in lung function are reported in PiZZ individuals. The annual decline in forced expiratory volume in one second (FEV1; Delta FEV1) was analysed in relation to smoking status in a cohort of 608 adult PiZZ individuals included in the Swedish national AAT deficiency register, Delta FEV1 was analysed in 211 never-smokers, in 351 exsmokers, and in 46 current smokers after performing at least two spirometries during a follow-up time of 1 yr or longer (median 5.5 yrs, range 1-31), The adjusted mean Delta FEV1 in never-smokers was 47 mL.yr(-1) (95% confidence interval (CI) 41-53 mL.yr(-1)), 41 mL.yr(-1) (95% CI 36-48 ml yr(-1)) in exsmokers, and 70 mL yr(-1) (95% CI58-82 mL.yr(-1)) in current smokers, A dose-response relationship was found between cigarette consumption and Delta FEV1 in current smokers and exsmokers, In never-smokers, a greater Delta FEV1 was found after 50 yrs of age than before. No sex differences were found in Delta FEV1. In conclusion, among PiZZ individuals, the change in forced expiratory volume in one second is essentially the same in never-smokers and exsmokers, Smoking is associated with a dose-dependent increase in the change in forced expiratory volume in one second.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 31 条
[1]   EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[2]  
BERGLUND E, 1963, ACTA MED SCAND, V173, P185
[3]   CLINICAL-FEATURES AND HISTORY OF THE DESTRUCTIVE LUNG-DISEASE ASSOCIATED WITH ALPHA-1-ANTITRYPSIN DEFICIENCY OF ADULTS WITH PULMONARY SYMPTOMS [J].
BRANTLY, ML ;
PAUL, LD ;
MILLER, BH ;
FALK, RT ;
WU, M ;
CRYSTAL, RG .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (02) :327-336
[4]  
BUIST AS, 1983, AM REV RESPIR DIS, V127, pS43
[5]   THE COURSE AND PROGNOSIS OF DIFFERENT FORMS OF CHRONIC AIRWAYS OBSTRUCTION IN A SAMPLE FROM THE GENERAL-POPULATION [J].
BURROWS, B ;
BLOOM, JW ;
TRAVER, GA ;
CLINE, MG .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (21) :1309-1314
[6]  
ERIKSSON S, 1965, ACTA MED SCAND, VS177, P5
[7]  
Fletcher C, 1976, NATURAL HIST CHRONIC
[8]   Alpha-1-antitrypsin replacement therapy: will its efficacy ever be proved? [J].
Hutchison, DCS ;
Hughes, MD .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (10) :2191-2193
[9]  
HUTCHISON DCS, 1987, PULMONARY EMPHYSEMA, P7
[10]  
JANUS ED, 1985, LANCET, V1, P152